# EDGAR Filing Document

**Accession Number:** 0001900304
**File Stem:** 0001654954-25-008997
**Filing Date:** 2025-8
**Character Count:** 8301
**Document Hash:** 368cc1e18194df30e81affb11c044a4e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001654954-25-008997.hdr.sgml**: 20250805

**ACCESSION NUMBER**: 0001654954-25-008997

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250805

**FILED AS OF DATE**: 20250805

**DATE AS OF CHANGE**: 20250805

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Haleon plc
- **CENTRAL INDEX KEY:** 0001900304
- **STANDARD INDUSTRIAL CLASSIFICATION:** PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** X0
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41411
- **FILM NUMBER:** 251183633

**BUSINESS ADDRESS:**
- **STREET 1:** BUILDING 5, FIRST FLOOR
- **STREET 2:** THE HEIGHTS
- **CITY:** WEYBRIDGE
- **STATE:** X0
- **ZIP:** KT13 0NY
- **BUSINESS PHONE:** 44 1932 822000

**MAIL ADDRESS:**
- **STREET 1:** BUILDING 5, FIRST FLOOR
- **STREET 2:** THE HEIGHTS
- **CITY:** WEYBRIDGE
- **STATE:** X0
- **ZIP:** KT13 0NY

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DRVW 2022 Ltd
- **DATE OF NAME CHANGE:** 20211217

**UNITED STATES**

 **SECURITIES AND EXCHANGE COMMISSION**

 **Washington, D.C. 20549**

 **FORM 6-K**

 **REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934**

 **For the month of August 2025**

 **Commission File Number: 001-41411**

 **Haleon plc**

(Translation of registrant's name into English)

 **Building 5, First Floor, The Heights,**

 **Weybridge, Surrey, KT13 0NY**

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

 **EXHIBIT INDEX**

<u> <u>Exhibit Number</u> </u> <u> <u>Description</u> </u> <br> <u> 99.1 </u> <u> 05 August 2025 - "Director/PDMR Shareholding" </u>

99.1 ![](a0166u000.jpg)

**Haleon plc**: **Director/PDMR Shareholding** 

 **5 August 2025:** Haleon plc (the "Company" or "Haleon") (LSE/NYSE:HLN) today announces notification and public disclosure in accordance with the requirements of The UK Market Abuse Regulation of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs").

On 1 August 2025, Ed Petter, Chief Corporate Affairs Officer, received the vesting of the second tranche of an award of Haleon Ordinary Shares under the Haleon Share Value Plan. The award was granted as part of his remuneration arrangements upon joining Haleon, to compensate for forfeited incentives from his previous employment.

The award is subject to malus and clawback provisions.

Further details are set out in the below notification, made in accordance with the requirements of The UK Market Abuse Regulations.

---

| | | | |
|:---|:---|:---|:---|
| **1** <br>| **Details of the person discharging managerial responsibilities / person closely associated**  | **Details of the person discharging managerial responsibilities / person closely associated**  | **Details of the person discharging managerial responsibilities / person closely associated**  |
| a) <br>| Name  | Ed Petter | Ed Petter |
| **2** <br>| **Reason for the notification**  | **Reason for the notification**  | **Reason for the notification**  |
| a) <br>| Position/status  | Chief Corporate Affairs Officer | Chief Corporate Affairs Officer |
| b) <br>| Initial notification /Amendment  | Initial Notification  | Initial Notification  |
| **3** <br>| **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor**  | **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor**  | **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor**  |
| a) <br>| Name  | Haleon plc  | Haleon plc  |
| b) <br>| LEI  | 549300PSB3WWEODCUP19  | 549300PSB3WWEODCUP19  |
| **4** <br>| **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted**  | **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted**  | **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted**  |
| a)  | Description of the financial instrument, type of instrument  | Ordinary Shares of £0.01 each | Ordinary Shares of £0.01 each |
| a)  |  |  |  |
| a)  | Identification code  | GB00BMX86B70  | GB00BMX86B70  |
| a)  |  |  |  |
| b) <br>| Nature of the transaction  | Acquisition of Ordinary Shares in respect of a vesting of the Haleon plc Share Value Plan (Buyout award). | Acquisition of Ordinary Shares in respect of a vesting of the Haleon plc Share Value Plan (Buyout award). |
| c)  | Price(s) and volume(s)  |  |  |
| c)  | Price(s) and volume(s)  | Price(s)  | Volume(s)  |
| c)  | Price(s) and volume(s)  | Nil | 112924 |
| c)  | Price(s) and volume(s)  |  |  |
| d) <br>| Aggregated information<br>- Aggregated volume<br>- Price  | <br>N/A | <br>N/A |
| e) <br>| Date of the transaction  | 1 August 2025 | 1 August 2025 |
| f) <br>| Place of the transaction  | Outside a trading venue | Outside a trading venue |
| **4** <br>| **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted**  | **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted**  | **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted**  |
| a)  | Description of the financial instrument, type of instrument  | Ordinary Shares of £0.01 each | Ordinary Shares of £0.01 each |
| a)  |  |  |  |
| a)  | Identification code  | GB00BMX86B70  | GB00BMX86B70  |
| a)  |  |  |  |
| b) <br>| Nature of the transaction  | Automatic disposal of Ordinary Shares resulting from Haleon plc Share Value Plan (Buyout award) vesting to cover tax liabilities. | Automatic disposal of Ordinary Shares resulting from Haleon plc Share Value Plan (Buyout award) vesting to cover tax liabilities. |
| c)  | Price(s) and volume(s)  |  |  |
| c)  | Price(s) and volume(s)  | Price(s)  | Volume(s)  |
| c)  | Price(s) and volume(s)  | £3.639 | 53207.298246 |
| c)  | Price(s) and volume(s)  |  |  |
| d) <br>| Aggregated information<br>- Aggregated volume <br>- Price  | <br>N/A | <br>N/A |
| e) <br>| Date of the transaction  | 1 August 2025 | 1 August 2025 |
| f) <br>| Place of the transaction  | London Stock Exchange (XLON)  | London Stock Exchange (XLON)  |

---

 **Amanda Mellor**

 **Company Secretary**

 **About Haleon**

Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as *Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu* and *Voltaren* - are built on trusted science, innovation and deep human understanding.

For more information, please visit <u>www.haleon.com</u>.

 **SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  |  | **HALEON PLC**<br> *(Registrant)* | **HALEON PLC**<br> *(Registrant)* |
| Date: August 05, 2025 | By: | /s/ Amanda Mellor | /s/ Amanda Mellor |
|  |  | Name: | Amanda Mellor |
|  |  | Title: | Company Secretary |

---